Neuropathologic diagnosis of Alzheimer disease: Consensus between practicing neuropathologists?

Alzheimer Disease and Associated Disorders

Volumn 11, Issue 4, 1997, Pages 207-219

  Bancher, Christian ^a,c   Paulus, Werner ^b   Paukner, Karl ^a   Jellinger, Kurt ^a  

^a GENERAL HOSPITAL LINZ   (Austria)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Alzheimer disease; Diagnostic criteria; Neuropathology; Questionnaire

Indexed keywords

THIOFLAVINE;

AGING; ALZHEIMER DISEASE; ARTICLE; AUSTRIA; AUTOPSY; DIAGNOSTIC PROCEDURE; GERMANY; HIPPOCAMPUS; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SENILE PLAQUE; SILVER STAINING; STAINING; SWITZERLAND;

ALZHEIMER DISEASE; BRAIN; HUMANS; NEUROLOGY; PATHOLOGY; QUESTIONNAIRES; STAINING AND LABELING;

EID: 0031457956     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Arriagada PV, Growdon JH, Hedley-Whyte T, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-9.
2. Bancher C, Braak H, Fischer P, Jellinger K. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 1993;162:179-82.
3. Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F. Correlations between mental state and quantitative neuropathology in the Vienna Prospective Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci 1996a;246:137-46.
4. Bancher C, Jellinger K, Eder H. Selective visualization of cortical Lewy bodies by immunocytochemical double-labelling: an aid in the diagnosis of combined pathologies. Neurobiol Aging 1996b;17:S120.
5. Bennett DA, Cochran EJ, Saper CB, Leverenz JB, Gilley DW, Wilson RS. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Neurobiol Aging 1993;14:589-6.
6. Bierer LM, Hof PR, Purohit DP, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995;52:81-8.
7. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
8. Campbell SK, Switzer RC, Martin TL. Alzheimer's plaques and tangles: a controlled and enhanced silver staining method. Soc Neurosci Abstr 1987;13:678.
9. Chui HC, Tierney M, Zarow C, Lewis A, Sobel E, Perlmutter LS. Neuropathologic diagnosis of Alzheimer disease: interrater reliability in the assessment of senile plaques and neurofibrillary tangles. Alzheimer Dis Assoc Disord 1993;7:48-54.
10. Crystal H, Dickson D, Fuld P, et al. Clinico-pathological studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988;38:1682-7.
11. Crystal HA, Dickson DW, Slowinski MJ, et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 1993;34:566-73.
12. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathologic aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1991;13:179-89.
13. Duyckaerts C, Brion J-P, Hauw J-J, Flament-Durand J. Quantitative assessment of the density of neurofibrillary tangles and senile plaques in senile dementia of the Alzheimer type. Comparison of immunocytochemistry with a specific antibody and Bodian's protargol method. Acta Neuropathol 1987;73:167-70.
14. Duyckaerts C, Delaere P, Hauw JJ, et al. Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories. A European multicenter study under the auspices of EURAGE. J Neurol Sci 1990;97:295-323.
15. Evans DA, Beckett LA, Albert MS, et al. Level of education and change in cognitive function in a community population of older persons. Ann Epidemiol 1993;3:71-7.
16. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971;19:1-8.
17. Hansen LA, Masliah E, Galasko D, Terry RD. Plaque-only Alzheimer disease is usually the Lewy body variant and vice versa. J Neuropathol Exp Neurol 1993;52:648-54.
18. He Y, Duyckaerts C, Delaere P, Piette F, Hauw J-J. Alzheimer's lesions labelled by anti-ubiquitin antibodies: comparison with other staining techniques. A study of 15 cases with graded intellectual status in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 1993;19:364-71.
19. Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM, eds. Alzheimer's disease: biology, diagnosis and the therapeutics. Chichester: John Wiley & Sons, 1997:185-8.
20. Jellinger K, Bancher C, Fischer P, Lassmann H. Quantitative histopathologic validation of senile dementia of the Alzheimer type Eur J Gerontol 1992;3:146-56.
21. Jellinger KA, Bancher C. Classification of dementias based on functional morphology. In: Jellinger KA, Ladurner G, Windisch M, eds. New trends in the diagnosis and therapy of Alzheimer's disease. New York, Wien: Springer-Verlag, 1994:9-39.
22. Jellinger KA, Bancher C, Fischer P. Letter to the editor. J Neuropathol Exp Neurol 1995;54:129-30.
23. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138-44.
24. Kazee AM, Eskin TA, Lapham LW, Gabriel KR, McDaniel KD, Hamill RW. Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria. Alzheimer Dis Assoc Disord 1993;7:152-64.
25. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105.
26. Klatka LA, Schiffer RB, Powers JM, Kazee AM. Incorrect diagnosis of Alzheimer's disease: a clinicopathologic study. Arch Neurol 1996;53: 35-42.
27. Lamy C, Duyckaerts C, Delaere P, et al. Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elederly patients. Neuropathol Appl Neurobiol 1989;15:563-78.
28. Langui D, Probst AS, Ulrich J. Alzheimer's changes in non-demented and demented patients: a statistical approach to their relationships. Acta Neuropathol 1995;89:57-62.
29. Mann DMA, Marcyniuk B, Yates PO, Neary D, Snowden JS. The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appl Neurobiol 1988;14:177-95.
30. McKee AC, Kosik KS, Kowall NW. Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol 1992;30:156-65.
31. McKeel DW Jr, Ball MJ, Price JL, et al. Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord 1993; 7:136-53.
32. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease: a primer for practicing pathologists. Arch Pathol Lab Med 1993; 117:132-44.
33. Mirra SS, Gearing M, McKeel DW Jr, et al. Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's disease (CERAD). J Neuropathol Exp Neurol 1994;53:303-15.
34. Morris JC, McKeel DW Jr, Storandt M, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991;41:469-78.
35. Morris JC, Storandt M, McKeel DW Jr, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-19.
36. Nagy Z, Esiri MM, Jobst KA, et al. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia 1995;6:21-31.
37. Ohm TG, Müller H, Braak H, Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 1995;64:209-17.
38. Paulus W, Bancher C, Jellinger K. Interrater reliability in the neuropathologic diagnosis of Alzheimer's disease. Neurology 1992;42: 329-32.
39. Reusche E. Silver staining of senile plaques and neurofibrillary tangles in paraffin sections; a simple and effective method. Pathol Res Pract 1991;187:1045-9.
40. Rosenblum WI. Letter to the editor. J Neuropathol Exp Neurol 1996;55:131.
41. Shin R-W, Ogomori K, Kitamoto T, Tateishi J. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease. Am J Pathol 1989;134:1365-71.
42. Stern Y, Gurland B, Tatemichi TK, Ming Xin Tang, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-10.
43. Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 1987;46:262-8.
44. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of possible Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988;38:359-64.
45. Wang D, Munoz DG. Qualitative and quantitative differences in senile plaque dystrophic neuntes of Alzheimer's disease and normal aged brain. J Neuropathol Exp Neurol 1995;54:548-56.
46. Wisniewski HM, Rabe A, Zigman W, Silverman W. Editorial: neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 1989a;48:606-9.
47. Wisniewski HM, Wen GY, Kim KS. Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol 1989b;78:22-7.
48. Yamamoto T, Hirano A. A comparative study of modified Bielschowsky, Bodian and thioflavin S stain on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol 1986;12:3-9.
49. Xuereb JH, Gertz HJ, Huppert F, Brayne C, Wischik CM, Mukaetova-Ladinska E. The application of Braak's staging model of Alzheimer-type pathology to neuropathological diagnosis of dementia [Abstract]. Neuropathol Appl Neurobiol 1995;21:441.